Sotac Pharmaceuticals Schedules Board Meeting on 13th Nov'26 to Consider H1 Results
Sotac Pharmaceuticals Ltd 路 Intimation 路 13 Nov 2026, 5:30 am
Sotac Pharmaceuticals Schedules Board Meeting on 13th Nov'26 to Consider H1 Results Sotac Pharmaceuticals Limited has informed the exchange that a meeting of its Board of Directors is scheduled to be held on 13th Nov'26. The board will primarily meet to consider and approve the company's half-yearly unaudited financial results for the period ended Sep'26, alongside other general business matters.
More announcements from Sotac Pharmaceuticals Ltd
- Sotac Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 13 Nov 2026
- Sotac Pharmaceuticals Limited has informed the Exchange about General Updates regarding Clarification in price movement. 路 05 Nov 2026
- Significant movement in price has been observed in Sotac Pharmaceuticals Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited. 路 03 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 and other business matters 路 13 Nov 2026
- Sotac Pharmaceuticals Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company. 路 03 Nov 2026
- Sotac Pharmaceuticals Limited has submitted the Exchange a copy Srutinizers report of Extraordinary General Meeting held on October 31, 2026. Further, the company has informed the Exchange regarding voting results. 路 02 Nov 2026
- Sotac Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Extraordinary General Meeting held on October 31, 2026 路 31 Oct 2026
- Sotac Pharmaceuticals Limited has informed the Exchange regarding Notice of Extraordinary General Meeting to be held on October 31, 2026 路 08 Oct 2026
